摘要
吉西他滨(gemcitabine,GEM)为抗嘧啶核苷酸代谢类药物。目前,GEM的标准给药方式为1 000~1 250 mg·m-2,30min静脉快速输注。但是,药理学研究表明,GEM延时输注可使细胞内有活性的GEM三磷酸盐达到最佳的蓄积速度,提示GEM延时输注在药动学方面要优于30 min快速输注。故本文对GEM低剂量延时输注的相关研究进行综述,以期为临床用药提供相关依据。
Gemcitabine(GEM) is a kind of anti-pyrimidine nucleotide metabolism drug. At present, the standard dose of GEM is 1 000-1 250 mg·m^-2, intravenous infusion for 30 min. However, pharmacological studies have shown that GEM with prolonged infusion can improve the accumulation rate of GEM triphosphate(d Fd CTP), suggesting that prolonged infusion of GEM is superior to 30 min infusion in pharmacokinetics. This paper review the related research of GEM with prolonged low-dose infusion in order to provide the basis for it's clinical medication.
作者
赵德华
楚明明
陈静
龚晶淼
孙丽琼
罗文
曹莉莎
刘真宏
王继生
ZHAO Dehua;CHU Mingming;CHEN Jing;GONG Jingmiao;SUN Liqiong;LUO Wen;CAO Lisha;LIU Zhenhong;WANG Jisheng(Department of Clinical Pharmacy,The Third Hospital of Mianyang,Mianyang 621000 China;Department of Clinical Pharmacy,The Second Affiliated Hospital of Third Military Medical University,Chongqing 400037,China)
出处
《中国现代应用药学》
CAS
CSCD
北大核心
2018年第7期1107-1111,共5页
Chinese Journal of Modern Applied Pharmacy
关键词
吉西他滨
低剂量
快速输注
延时输注
药动学
Gemcitabine
low-dose
rapid infusion
prolonged infusion
pharmacokinetics